SummaryObjectivesTo compare costs and clinical benefits of three additional therapies to metformin (MF) for patients with diabetes mellitus type 2 (DM2).MethodsA discrete event simulation model was built to estimate the cost-utility ratio (cost per quality-adjusted life years [QALY]) of saxagliptine as an additional therapy to MF when compared to rosiglitazone or pioglitazone. A budget impact model (BIM) was built to simulate the economic impact of saxagliptine use in the context of the Brazilian private health system.ResultsThe acquiring medication costs for the hypothetical patient group analyzed in a time frame of three years were R$ 10,850,185, R$ 14,836,265 and R$ 14,679,099 for saxagliptine, pioglitazone and rosiglitazone, respectivel...
Class of 2008 AbstractObjectives: To determine the cost-effectiveness of adding a thiazolidinedione ...
Metformin and metformin-glimepiride are cost-effective therapy options and are most commonly prescri...
Back ground: Diabetes mellitus is a chronic lifelong disease, requiring long term expensive treatmen...
Objectives: To compare costs and clinical benefits of three additional therapies to metformin (MF) f...
SummaryObjectivesTo compare costs and clinical benefits of three additional therapies to metformin (...
OBJETIVOS: Comparar custos e benefícios clínicos de três terapias adicionais à metformina (MF) para ...
Background. Metformin is a widely accepted first-line pharmacotherapy for patients with type 2 diabe...
This study assessed the long-term cost-effectiveness of saxagliptin+metformin (SAXA+MET) versus acar...
This study assessed the long-term cost-effectiveness of saxagliptin+metformin (SAXA+MET) versus acar...
ResumoObjetivosComparar custos e benefícios clínicos de três terapias adicionais à metformina (MF) p...
Background: The increasing prevalence of diabetes and its inadequate management results in a heavy b...
Abstract Objective: To evaluate long-run cost-effectiveness in a Swedish setting for liraglutide com...
Background: With the available evidence of early combined oral drug therapies being more effective i...
Abstract Background Patients with type 2 diabetes (T2D) typically use several drug treatments during...
Abstract Objectives This study was designed to assess the cost-effectiveness of vildagliptin versus ...
Class of 2008 AbstractObjectives: To determine the cost-effectiveness of adding a thiazolidinedione ...
Metformin and metformin-glimepiride are cost-effective therapy options and are most commonly prescri...
Back ground: Diabetes mellitus is a chronic lifelong disease, requiring long term expensive treatmen...
Objectives: To compare costs and clinical benefits of three additional therapies to metformin (MF) f...
SummaryObjectivesTo compare costs and clinical benefits of three additional therapies to metformin (...
OBJETIVOS: Comparar custos e benefícios clínicos de três terapias adicionais à metformina (MF) para ...
Background. Metformin is a widely accepted first-line pharmacotherapy for patients with type 2 diabe...
This study assessed the long-term cost-effectiveness of saxagliptin+metformin (SAXA+MET) versus acar...
This study assessed the long-term cost-effectiveness of saxagliptin+metformin (SAXA+MET) versus acar...
ResumoObjetivosComparar custos e benefícios clínicos de três terapias adicionais à metformina (MF) p...
Background: The increasing prevalence of diabetes and its inadequate management results in a heavy b...
Abstract Objective: To evaluate long-run cost-effectiveness in a Swedish setting for liraglutide com...
Background: With the available evidence of early combined oral drug therapies being more effective i...
Abstract Background Patients with type 2 diabetes (T2D) typically use several drug treatments during...
Abstract Objectives This study was designed to assess the cost-effectiveness of vildagliptin versus ...
Class of 2008 AbstractObjectives: To determine the cost-effectiveness of adding a thiazolidinedione ...
Metformin and metformin-glimepiride are cost-effective therapy options and are most commonly prescri...
Back ground: Diabetes mellitus is a chronic lifelong disease, requiring long term expensive treatmen...